Pfizer Petitions FDA to Extend Market Exclusivity for Combo Drug Duavee

Drug Industry Daily
A A
Pfizer is pressing the FDA to extend the market exclusivity of its combination drug Duavee, following a judge’s ruling that the FDA had inconsistently interpreted the eligibility criteria.

To View This Article:

Login

Subscribe To Drug Industry Daily